Phenotypic screening in drug discovery continues to be revived With all the expectation of offering promising lead compounds and drug targets and increasing the good results price of drug approval. However, concentrate on identification stays a major bottleneck in phenotype-centered drug discovery. We recognized the lead compounds K542 and K405 https://friedrichj676alb1.activosblog.com/profile